The rates of death are high among patients with coinfection with tuberculosis and the human immunodeficiency virus (HIV). The optimal timing for the initiation of antiretroviral therapy in relation to tuberculosis therapy remains controversial
Artículo de publicación ISIBackground: Antiretroviral therapy (ART) decreases mortality risk in HIV-...
Background: Initiation of antiretroviral therapy (ART) during tuberculosis (TB) treatment remains ch...
AbstractBackgroundFor antiretroviral therapy (ART) naive human immunodeficiency virus (HIV) infected...
Background. The rates of death are high among patients with coinfection with tuberculosis and the hu...
Despite high mortality rates in tuberculosis patients with HIV co-infection, there is continued cont...
Tuberculosis remains an important cause of death among patients infected with the human immunodefici...
BACKGROUND: We previously reported that integrating antiretroviral therapy (ART) with tuberculosis t...
Abstract: Background: HIV and tuberculosis are frequently diagnosed concurrently. In March 2021, Wor...
Background. We previously reported that integrating antiretroviral therapy (ART) with tuberculosis t...
Background: HIV and tuberculosis are frequently diagnosed concurrently. In March 2021, World Health ...
BACKGROUND: HIV and tuberculosis are frequently diagnosed concurrently. In March 2021, World Health ...
BACKGROUND: For antiretroviral therapy (ART) naive human immunodeficiency virus (HIV) infected adult...
Presented in part at the 18th International AIDS Conference, Vienna, July 18–23, 2010International a...
Background. HIV-associated tuberculosis (TB) is common in South Africa. The optimal time for initiat...
Background: Integration of antiretroviral (ART) and tuberculosis (TB) therapy has been shown to imp...
Artículo de publicación ISIBackground: Antiretroviral therapy (ART) decreases mortality risk in HIV-...
Background: Initiation of antiretroviral therapy (ART) during tuberculosis (TB) treatment remains ch...
AbstractBackgroundFor antiretroviral therapy (ART) naive human immunodeficiency virus (HIV) infected...
Background. The rates of death are high among patients with coinfection with tuberculosis and the hu...
Despite high mortality rates in tuberculosis patients with HIV co-infection, there is continued cont...
Tuberculosis remains an important cause of death among patients infected with the human immunodefici...
BACKGROUND: We previously reported that integrating antiretroviral therapy (ART) with tuberculosis t...
Abstract: Background: HIV and tuberculosis are frequently diagnosed concurrently. In March 2021, Wor...
Background. We previously reported that integrating antiretroviral therapy (ART) with tuberculosis t...
Background: HIV and tuberculosis are frequently diagnosed concurrently. In March 2021, World Health ...
BACKGROUND: HIV and tuberculosis are frequently diagnosed concurrently. In March 2021, World Health ...
BACKGROUND: For antiretroviral therapy (ART) naive human immunodeficiency virus (HIV) infected adult...
Presented in part at the 18th International AIDS Conference, Vienna, July 18–23, 2010International a...
Background. HIV-associated tuberculosis (TB) is common in South Africa. The optimal time for initiat...
Background: Integration of antiretroviral (ART) and tuberculosis (TB) therapy has been shown to imp...
Artículo de publicación ISIBackground: Antiretroviral therapy (ART) decreases mortality risk in HIV-...
Background: Initiation of antiretroviral therapy (ART) during tuberculosis (TB) treatment remains ch...
AbstractBackgroundFor antiretroviral therapy (ART) naive human immunodeficiency virus (HIV) infected...